Kartikeya Cherabuddi

2.2k citations
44 papers · 1.2k indexed · 1 hit paper · h-index 17

Kartikeya Cherabuddi

38 papers receiving 1.1k citations

Hit Papers

Viable SARS-CoV-2 in the air of a hospital room with COVI...4862020202620222024100200300400

Peers

Kartikeya Cherabuddi
Comparison fields: 5 of 119
  • Applied Microbiology and Biotechnology 104
  • Modeling and Simulation 187
  • Molecular Medicine 167
  • Infectious Diseases 384
  • Endocrinology 76
Replace Erin Epson with:
Erin Epson United States
Se Yoon Park South Korea
David R. Jenkins United Kingdom
Camille Lemieux Canada
Koh Cheng Thoon Singapore
Tark Kim South Korea
Zahir Hirji Canada
Indumathi Venkatachalam Singapore
Tommaso Lupia Italy
Matthias Schlegel Switzerland
Kartikeya Cherabuddi relative to Erin Epson United States Erin Epson's profile →
Citations per field
00.5×1.5×2.5×
Erin Epson · 1×
Citations per year

Countries citing papers authored by Kartikeya Cherabuddi

Since Specialization
Citations

This map shows the geographic impact of Kartikeya Cherabuddi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kartikeya Cherabuddi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kartikeya Cherabuddi more than expected).

Fields of papers citing papers by Kartikeya Cherabuddi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kartikeya Cherabuddi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kartikeya Cherabuddi. The network helps show where Kartikeya Cherabuddi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kartikeya Cherabuddi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kartikeya Cherabuddi Line = papers co-authored together Kartikeya Cherabuddi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20245
4 20238
5 20237
6 202218
7 20228
8 202036
9 202010
10
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patientsbreakdown →
2020486
11 20197
12 201910
13 201816
14 201736
15 20175
16 201733
17 20172
18 20172
19 201641
20 201278

About Kartikeya Cherabuddi

Kartikeya Cherabuddi is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pneumonia and Respiratory Infections (8 papers), Antibiotic Resistance in Bacteria (6 papers), Urinary Tract Infections Management (6 papers), Bacterial Identification and Susceptibility Testing (6 papers), Antibiotic Use and Resistance (5 papers), Nosocomial Infections in ICU (4 papers) and Viral Infections and Vectors (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (104 citations), Modeling and Simulation (187 citations) and Molecular Medicine (167 citations). Kartikeya Cherabuddi has collaborated with scholars based in United States, India and Italy. Frequent co-authors include John A. Lednicky, J. Glenn Morris, Kenneth Klinker, Julia C. Loeb, Veena Venugopalan, Caroline J. Stephenson, Kuttichantran Subramaniam, Maha A. Elbadry, Thomas B. Waltzek and Trevor B. Tilly. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026